Results 171 to 180 of about 6,618,541 (298)
Cramer-Rao Lower Bound for SoOp-R-Based Root-Zone Soil Moisture Remote Sensing. [PDF]
Boyd DR +7 more
europepmc +1 more source
Translating whole‐genome doubling into precision medicine in cancer
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley +1 more source
On Applying Unit Propagation-Based Lower Bounds in Pseudo-Boolean Optimization
Unit propagation-based (UP) lower bounds are used in the vast majority of current Max-SAT solvers. However, lower bounds based on UP have seldom been applied in Pseudo-Boolean Optimization (PBO) algorithms derived from the DPLL procedure for ...
Heras, Federico +5 more
core
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Near-Frustration-Free Electronic Structure Hamiltonian Representations and Lower-Bound Certificates. [PDF]
Rubin NC, Low GH, DePrince Iii AE.
europepmc +1 more source
Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization. [PDF]
Paul Friedman K +21 more
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Approximate Cramér-Rao lower bound analyses for semi-optimal energy thresholds selection in photon counting CT. [PDF]
Lee O.
europepmc +1 more source

